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Summary: One hundred and sixteen insulin treated diabetic patients were evaluated for the relationship
between the presence of microalbuminuria and several lipid, glyco-metabolic, coagulation and fibrinolysis
factors. A significant correlation existed only between microalbuminuria and HbAlc (r = 0.23, p = 0.008)
and D-dimer (r = 0.28, p = 0.002). After the subdivision of the patients in a group without (n = 85) and a
group with microalbuminuria (n = 31) significant differences were found between these two groups for the
HDL-cholesterol content (p < 0.05), the HbAic level (p < 0.01) and for the D-dimer concentration (p < 0.01).
Comparison of the patient groups without and with microalbuminuria separately with a healthy volunteers
group without albuminuria resulted in significant differences for HDL-cholesterol, triacylglycerols, HbAlc,
fructosamine, fibrin monömer and D-dimer, whereas fibrinogen also was significantly different between the
diabetic group without microalbuminuria and the healthy volunteers group. Several factors predisposing for
atherosclerosis (decrease of HDL-cholesterol, increase of triacylglycerols, coagulation activation with relatively
msufficient fibrinolysis) were nöticed in both diabetic groups without or with microalbuminuria, but more
pronounced in the latter group. The appliance of a Receiver Operating Characteristic (ROC) curve for HbAJC
against microalbuminuria (cuf-off level 20 g/min) reconfirmed the value of adequate glycaemic control in
diabetics for the prevention of microalbuminuria. In conclusion the results of this study show a significantly
pporer glycaemic control in insulin treated diabetics with microalbuminuria than in those without microal-
buminuria. The presence of lower HDL-cholesterol, higher triacylglycerols and the elevation of fibrin mon-
omers and D-dimers is more pronoüiiced in the microalbuminuria group. No direct correlation could however
be found between the coagulation.and fibrinolysis factors and the extent of microalbuminuria in the diabetic
patient groups.
Introduction (2). This stage can be defined äs the period in which
The occurrence of nücroalbuminuria (1) is accepted the mean urinary albumin excretion rate is signifi-
as an early indicator of microangiopathy in diabetes cantly higher (20—200 g/min) than that in reference
mellitus i. e: diabetic nephropathy. The onset of the subjects (3). The clinical syndrome of diabetic ne-
clinical Symptoms of diabetic nephropathy may be phropathy is characterised by persistent proteinuria
preceded by a silent period of variable duration düring (4), accompanied by increased morbidity and mortal-
which diabetic patients show only microalbuminuria ity in diabetic patients (5 — 11). Düring the stage of
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clinical proteinuria and progressive renal failure, there
are changes in the plasma lipoprotein concentration
(12-14) which are thought to contribute to the in-
creased cardiovascular risk. Recently, in a case-con-
trol study (15), the concentrations of lipoproteins,
apolipoproteins, fibrinogen and factor VII were com-
pared in insulin-dependent diabetic patients with
(n = 20) and without (n = 20) microalbuminuria un-
der similar glyco-metabolic control
In this study we have investigated the correlation
between the microalbuminuria and the following pa-
rameters: several lipid fractions (cholesterol, HDL-
cholesterol, LDL-cholesterol, triacylglycerol); para-
meters for glyco-metabolic control (HbAic and fruc-
tosamine) (16, 17); the routine clotting test fibrinogen;
sensitive indicators for clotting activation like fibrin
monomers and the thrombin-antithrombin-III com-
plex (18); and the fibrinolysis factors, plasminogen
activator inhibitor (19, 20) and D-Dimer, the latter
being a sensitive indicator of the onset of reactive
fibrinolysis (21). The aim of the study was to inves-
tigate the possibility that biochemical parameters
other than urinary microalbumin excretion rates pos-
sess predictive value for the occurrence of diabetic
angiopathy.
Materials and Methods
Methods
The serum samples were analysed with a Cobas Bio centrifugal
fast analyser and commercial test kits according to the manu-
facturer's instructions were used.
— Serum triacylglycerol:
Hoffmann La Röche, Basel, Switzerland, product No.
0710865
— total serum cholesterol:
Boehringer Mannheim, Germany, product no. 237574
- Serum HDL cholesterol:
Boehringer Mannheim, Germany, product No. 543004
— Serum LDL cholesterol:
calculated by applying the Friedewald equation
— HbA,c in haemolysate:
Bio Rad ion exchange column chromatography, product
No. 192-8001
— Serum fructosamine:
Hoffmann La Röche, Basel, Switzerland, product No
0711217.
The test was performed according to the method of Johnson
et al. (17) on a Cobas Bio centrifugal analyser
— Plasma D-Dimer:
For the Elisa D-dimer determinations we used the test kit
of Boehringer Mannheim, product No. 998117. The meas-
urements were carried out on the Bio Rad micro-titre reader
System. The reactions were performed in polystyrene micro-
titre plates of the Nunc Corporation
— Plasma plasminogen activator inhibitor:
Test kit of Kabi Vitrum COA-SET PAL
— Plasma thrombin-antithrombin III:
Elisa test kit Enzygnost-TAT, Behring, Hoechst, Marburg
(Germany), product No. OURC 10/11
— Fibrinogen: ·'
Turbidimetric method of Behring, using the CTS-fibrinogen
reagent on the Chromotirne System (Behring).
— Fibrin monomers:
chromogenic COA-set FM test Kabi Vitrum Diagnostica.
— Urinary microalbumin:
immunoturbidimetric test of Orion Diagnostica Corpora-
tion, product No. 67352
Patients
One hundred and sixteeii uisuüii^treated diabetic patients, con-
sisting of 47 males (riiean age 55.3 years, fange 20—80) and 69
females (mean age 60.1 years, ränge 30—82) were inclüded in
the study. The percentage of patients with ihieroalbuminuria
(i. e. 20—200 g urinary albumin excreted per min) was 26.7%.
Patients with a urinary albumin excreeding 200 ^ per min
were excluded from the study. The co-medication of the patients
inclüded in the study consisted mainly pf ,oral anticoagulants
or acetyl-salicylic acid. Patients treated with antihypertensive
drugs or corticosteroids were excluded. The number of true
type l subjects was 62, equally divided between the two albumin
excretion groups. The general characteristics of the patients are
given in table 1. Retinopathy was diagnosed by fundoscopy
and fluprescence angiography. Neuropathy was diagnosed by
measurement of the Vibration sense and the presence of sensory
distürbance in the extremities. Blood samples were collected
when the patients attended the hpspital (St. Gregprius hospital,
Brunssum, The Netherlands) for their routine diabetic control
in the department for internal medicine. The refererice vaiues
were obtained from 50 subjectively healthy individuals, ranging
in age from 24 to 50 years. Reference ranges were taken to be
the mean vaiues ± 2 SD. ' · %
Samples
We collected venous blood samples between 8.30 and 9.00 a.rn.
and prepared citrated plasma by centrifugation of niiie volumes
of freshly drawn blood with one volume of trisodium citrate
(0.11 mol/1) for 30 min at 25 °C (1600 g). The plasma was used
immediately or stored at --70 °C in plastic tubes and thawed
with tap water for 5 min before use. For the glyco-metabolic
determinations washed red cells were haemolysed and the hae-
molysate äs such was used for the Chromatographie Separation
of HbAic. Urine samples for urinary albumin determination
were obtained from a moraing portion after collecting over-
night, and the time of collection was recorded.
Statistics
Correlations between the different parameters and urinary mi-
croalbumin were investigated by the Spearman rank test. The
significance of the differences was assesseÖ by the Mann-Whit-
ney^Wilcoxon test. The sensitivity and specificity of HbAic and
Dfdimer were calculated according to the presence or absence
of microalbuminuria äs the decision Standard (cut-off level
20 g/min). Receiver Operating Characteristic (ROC) curves
for assessing the power of the teste were constructed äs de-
scribed earlier (22). ; r
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Tab. 1. General characteristics of the patients according to the albumin excretion rate. Values are means (SD). The number of
the patients with retinopathy, and neuropathy are given s percentages.
Diabetic patients
with albumin excretion rate
< 20 μ§/ππη;
mean 9.7, r nge 0—20
(n = 85)
Diabetic patients
with albumin excretion rate
20-200 μg/min;
mean 47.0, r nge 21—142
(n = 31)
Age (years)
Body mass index
Diastolic pressure
Systolic pressure
Duration of diabetes
Serum creatinine
Retinopathy
Neuropathy
(kg/m2)
(mmHg)
(mmHg)
(years)
(μπιοΐ/ΐ)
55.3
24.3
83
128
14.0
82.1
15.3%
7.1%
(16.1)
(3.5)
(6.9)
(10.4)
(8.7)
(12.0)
60.1
24.1
85
128
14.5
82.1
29.0%
12.9%
(14.8)
(4.6)
(8.1)
(15.8)
(9.7)
(15.8)
Results
The Spearman rank collection between urinary mi-
croalbumin concentrations and several biochemical
parameters is given in table 2. Significant correlations
with microalbuminuria were found only for HbAic
and D-dimer, with r values of 0.232 (p = 0.008 and
0.278 (p = 0.002) respectively. In table 3 the diabetic
patient groups without (< 20 μg/min) and with (> 20
μg/min) albuminuria are compared with a healthy
volunteers group without albuminuria. No significant
differences for either diabetic group were found for
cholesterol, cholesterol/HDL-cholesterol ratio, LDL-
cholesterol, thrombin-antithrombin III complex and
plasminogen activator inhibitor. Additionally, fibri-
nogen levels were not significantly altered in the group
with a high lb miri excretion rate. The other param-
eters showed highly significant differences betweeri
the two patient groups and the volunteer group. Mu-
tual comparison of the two patient groups s given
in table 4 showed a significant decrease for HDL-
Tab. 2. Spearman rank correlation between urinary micro k
bumin and several biochemical parameters in diabetic
patients.
Microalbumin
versus
parameter
Cholesterol
Cholesterol/HDL-cholesterol ratio
HDL-cholesterol
LDL-cholesterol
Triacylglycerols
HbAlc
Fructosamine
Fibrinogen
Fibrin monomers
Thrombin-antithrombin-III
Plasminogen activator inhibitbr
D-Dimer
r
0.04
0.01
-0.14
0.03
0.13
0.23
0.07
0.18
0.13
0.11
0.05
0.28
P
0.65
0.26
0.11
0.79
0.14
0.008
0.42
0.06
0.17
0.23
0.60
0.002
cholesterol (p < 0.05), and significant increases for
HbAlc (p < 0.01) and D-dimer (p < 0.01).
To assess the predictive power of the HbAJC in relation
to the microalbuminuria, a ROC-curve (fig. 1) was
calculated at different cut-off levels of the test against
microalbuminuria s the reference parameter at the
cut-off decision level 20 μg/min. For the HbAlc r nge
from 6% to 12% the sensitivity ranged from 38% to
100%, the specificity from 85% to 65%.
100 p
90
80
70
60
50·-
30
20
10 -
8 9 10 11
HbA1c[%of total Hb]
12 13
Fig. 1. Sensitivity (β) and specificity (A) at different HbAic
decision levels (reference cut-ofT parameter : urinary
microaibumin 20 μg/πιin).
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Tab. 3. Comparison of the healthy volunteers (group 1) with the two diabetic groups with (group 3)
microalbuminuria (Mann-Whithey-Wilcoxon test).
Variables
Cholesterol
Cholesterol/HDL-
cholesterol
HDL-cholesterol
LDL-cholesterol
Triacylglycerols
HbAlc
Fructosamine
Fibrinogen .
Fibrin monomer
Thrombin-
antithrombin-III
Plasminogen
activator inhibitor
D-Dimer
(mmol/1)
ratio
(mmol/1)
(mmol/1)
(mmol/1)
(%)
(mmol/1)
(g/0
(nmol/1)
(ΜΑ)
(ΙΟ3 AU/1)
fog/O
Albumin excretion rate
< 20 μg/min < 20 ]ig/min 20-200 μ§/αιΐη
Group of healthy Diabetics Diabetics
 t f
volunteers
Group 1 Group 2 Group 3
(n = 50) (n = 85) (n = 31)
Mean (SD) Mean (SD) Mean (SD)
5.8 (0.9) 6.2 (1.5) 6.0 (1.4)
5.3 (0.9) 5.2 (2.0) 6.0 (2.7)
1.5 (0.13) 1.27 (0.44) 1.1 (0.3)
4.0 (0.5) 3.9 (1.2) 3.9 (1.1)
1.4 (0.3) 2.49 (2.80) 2.24 (1.31)
5.5 (0.75) 7.9 (1.6) 8,8 (1.9)
2.9 (0.3) 2.2 (0.6) 3.5 (0.8)
3.8 (0.3) 3.4 (0.8) 3.7 (1.2)
10.8 (1.2) 13.9 (0.4) 13.7 (5.2)'
2.6 (0.8) 4.4 (11.8) 5.6 (10.8)
12.7 (6.3) 14.8 (11.1) 18.3 (11.4)
238 (100) 412 (356) 567 (468)
and without (group 2)
Significance level:
p-val e
G2/G1 G3/G1
ILS. n. s.
n. s. n. s.
1
< 0.001 < 0.0001 '
n. s. n. s.
<0.01 < 0.0001
< o.oooi < o.oooi ;
< 0.0001 < 0.0001
< 0.01 n. s. j
< 0.0001 < 0.0001 \
n. s. n. s. i
n, s. n. s. ;i
< 0.0001 < 0.0001
Tab. 4. Mutual comparison of the diabetic groups without (group 1) and with (group 2) microalbuminuria (Mann-Whitney-
Wilcoxon test).
Diabetics
Variable
Albumin excretion rate
^ 20 μg/min 20-200 μg/min
Group 2 Group 3 Significance level:p-value
χ (SD) χ (SD)
Cholesterol
Cholesterol/HDL-
cholesterol ratio
HDL-cholesterol
LDL-cholesterol
Triacylglycerols
HbAlc
Fructosamine
Fibrinogen
Fibrin monomer
Thrombin-
anti thrombin III
Plasminogen
activator inhibitor
D-Dimer
(mmol/1)
(mmol/1)
(mmol/1)
(mmol/1)
(%)
(mmol/1)
(g/l)
(nmol/1)
(μβ/1)
(ΙΟ3 AU/1)
(«/O
6.2 (1.5) 6.0 (1.4)
5.2 (2.0) 6.0 (2.7)
1.27 (0.44) 1.1 (0.3)
3.9 (1.2) 3.9 (1.1)
2.49 (2.80) 2.24 (131)
7.9 (1.6) 8.8 (1.9)
3.3 (0.6) 3.5 (0.8)
3.4 (0.8) 3.7 (1.2)
13.9 (4.9) 13.7 (5.2)
4.4 (11.8) 5.6 (10.8)
14.8 (11.1) 18.3 (11.4)
412 (356) 567 (468) > i
n. s.
n. s.
<0.05
n. s.
n. s.
<0.01
n. s.
n. s.
n·, s.
n. s.
n. s.
<0.01
Eur. J. Clin. Chem. Clin. Biochein. / Vol. 29,1991 / No. 8
van Wersch et al.: Microalbuminuria in diabetics: Relationship to other parameters 497
Discussion
The general characteristics of the studied diabetic
population, äs shown in table l, contain data that
need some clarification. The reported mean values for
blood pressure and urinary albumin excretion in pa-
tients with a mean duration of diabetes mellitus of 14
years indicate, äs mentioned in the patients section,
that patients with hypertension and "macroalbumi-
nuria" were excluded from the study. Possibly there-
fore we found no differences in mean systolic and
diastolic blood pressure between the diabetic patients
with and without microalbuminuria. The correlation
between microalbuminuria and several biochemical
Parameters was shown to be significant only for
HbAlc and D-dimer (tab. 2). These results suggest an
increased prevalence of microalbuminuria associated
with poorer glycaemic control and augmented reactive
fibrinolysis (probably after preceding coagulation ac-
tivation). Recently, we described an increase of co-
agulation activation with a decreased efficiency of
glyco-metabolic control (23), äs well äs a relative
decrease of the elevated reactive fibrinolysis with in-
creasing HbAic (24) in a large population of insulin-
dependent diabetic patients. Thus, the D-dimer level
might be an indirect indicator of long term sequelae
of diabetes mellitus such äs microalbuminuria.
Comparison of the insulin-dependent diabetics with
or without microalbuminuria with a group of healthy
individuals showed significant alterations in some
lipid parameters (HDL-cholesterol, triacylglycerol)
and in some coagulation and fibrinolysis parameters
(fibrin monomer, D-dimer). Several factors might be
responsible for the differences between the three
groups, but most probable is the influence of the
glycaemic control. In young insulin-dependent dia-
betics, the glyco-metabolic control state has been
shown to influence the lipoprotein serüm concentra-
tions (25—27) äs well äs the prevalence of microal-
buminuriä, whereäs changes in the lipid fractions have
been described in diabetics with microalbuminuria
and with pöor glycaemic eontrol (13).
Recently triacylglycerol has been reported to enhance
the activation of coagulation factor VII (28), leading
to thrombin formatipn and hence to fibrin monomer
formation and reactive fibrinolysis (D-dimers). Be-
catise serum triacylglycerol correlates with plasmino-
gen activator inhibitor, fibrinolysis might be impaired
when triacylglycerol is elevated (29). Möreover in-
creased serum triacylglycerol äs well äs elevated plas-
minogen activator inhibitor levels have been observed
to be strongly related to an enhanced risk of ischaemic
heart disease (30—34). The two diabetic groups of
the present study differ from the reference group with
respect to those parameters known to be correlated
with an enhanced risk of cardiovascular disease. In
the mutual comparison of the two diabetic patient
groups with and without microalbuminuria (tab. 4)
the HDL-cholesterol concentration, a known risk fac-
tor for cardiovascular disease, was significantly de-
creased in the microalbuminuria group. Moreover,
there appeared to be an enhanced clotting activation
(fibrin monomers) with reactive fibrinolysis (D-dimer)
in both diabetic groups, whereas HbAlc was higher in
the microalbuminuria group, indicating poorer gly-
caemic control. In view of the relative decrease of the
fibrinolysis level with increasing HbAlc which we re-
ported earlier (24), there might, however, be insuffi-
cient reactive fibrinolysis for the extent of the signal-
ized coagulation activation. For the testing of the
power of HbAic äs a predictive parameter for mi-
croalbuminuria we constructed a ROC curve for
HbAlc at different cut-off levels. The ROC curve
showed 100% sensitivity for the prediction of mi-
croalbuminuria (> 20 g/min) at a cut-off level of
12% HbAlc. Moreover, i t should be noted that be-
tween 11% and 12% HbAlc there is a jump in the
prediction sensitivity from 66.7 to 100%; which might
be another indication for setting the goal of glycaemic
control at least below the value of 11 % HbAic. Never-
theless it seems worthwile from the course of the ROC
curve to pursue a normoglycaemia, because in that
ränge a decrease of the sensitivity is achievable from
66.7% (at a HbAlc level of 11%) to 37.8% (at a
HbAlc level of 6%). This finding agrees with the
results Klein et al. (35), who demonstrated a strong
and consistent relation between hyperglycaemia and
the incidence and progression of retinopathy, and who
einphasized the importance of normoglycaemia in di-
abetics.
Conclusion
The results of this study show that in insulin-treated
diabetics with microalbuminuria glycaemic control is
significantly poorer than in the patients without mi-
croalbuminuria. Several abnormalities are signifi-
cantly more pronounced in the microalbuminuria
than in the non-microalbuminuria group; the lipid
fractions contain lower HDL-cholesterol and higher
triacylglycerol, which are prerequisites for the devel-
ppment of atherosclerosis. Of the coagulation and
fibrinolysis factors, the elevation of the fibrin mono-
mer and the D-dimer values should be noted, because
they indicate an activation of coagulation, possibly
with relatively insufficient reactive fibrinolysis in poor
glycaemic control, thereby possibly also constituting
risk factors for coronary heart disease. We did not,
however, observe a direct correlation between coag-
ulation and fibrinolysis and the existence of microal-
buminuria in the diabetic patient groups.
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